PMC:7195088 / 13075-13285 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"211","span":{"begin":178,"end":188},"obj":"Chemical"},{"id":"257","span":{"begin":109,"end":150},"obj":"Disease"}],"attributes":[{"id":"A211","pred":"tao:has_database_id","subj":"211","obj":"MESH:C000606551"},{"id":"A257","pred":"tao:has_database_id","subj":"257","obj":"MESH:D056486"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"e currently unavailable. Early discontinuation should be considered in the presence of adverse effects (e.g. QT prolongation or hepatic/renal toxicity). If the administration of remdesivir is approved within co"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T57","span":{"begin":178,"end":188},"obj":"Chemical"}],"attributes":[{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"}],"text":"e currently unavailable. Early discontinuation should be considered in the presence of adverse effects (e.g. QT prolongation or hepatic/renal toxicity). If the administration of remdesivir is approved within co"}

{"project":"LitCovid-sentences","denotations":[{"id":"T83","span":{"begin":25,"end":152},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"e currently unavailable. Early discontinuation should be considered in the presence of adverse effects (e.g. QT prolongation or hepatic/renal toxicity). If the administration of remdesivir is approved within co"}